share_log

Cerevel Therapeutics Holdings(CERE.US) Director Sells US$2.06 Million in Common Stocks

moomoo News ·  Mar 4 18:31

$Cerevel Therapeutics Holdings (CERE.US)$ Director COLES N ANTHONY sold 50,000 shares of Common Stocks on Feb 29, 2024 at an average price of $41.1578 for a total value of $2.06 million.

1709595112709615336.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment